Skip to content

Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women

Evaluation of Serum Hormone Levels Referenced to Ovulation in Subfertile Women With Regular Menses

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05211583
Enrollment
40
Registered
2022-01-27
Start date
2021-12-10
Completion date
2022-04-30
Last updated
2022-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovulation Disorder, Subfertility, Female

Keywords

ovulation, progesterone, ovulatory dysfunction, subfertility

Brief summary

Ovulatory dysfunction is identified in 15% of all infertile couples and it accounts for 40% of female infertility. Ovulatory dysfunction may be more subtle in women with regular menses. Detecting the day of ovulation is necessary for optimizing natural conception, diagnosis of cycle disturbances and also timing for embryo transfer in natural cycle frozen-thawed embryo transfers. In order to diagnose ovulatory dysfunction, ovulation physiology and change of reproductive hormones during the menstrual cycle should be understood. In the present study we aimed to evaluate serial serum hormonal cut-off levels referenced to ovulation in subfertile women with regular menses.

Interventions

In order to show change of serum progesterone levels, serial venous blood sampling will be done and also transvaginal ultrasonography will be performed to show ovulation.

Sponsors

Turgut Aydın
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* women that have regular menses (menstrual cycle length 21-35 days) * women who will come visits regularly * women that are trying to conceive more than 1 year if women age is less than 35 years or more than 6 months if women age is \>35 years

Exclusion criteria

* women who do not menstruate regularly * women that use hormonal contraception * women who take drugs that will interfere with steroid hormone metabolism

Design outcomes

Primary

MeasureTime frameDescription
Change of serum progesterone levels referenced to ovulationProgesterone levels will be measured serially when dominant follicule reaches 17 mm in diameter and after that 1-2 days interval until to ovulation; 1 week after ultrasound and hormone-detected ovulationSerum progesterone levels will be measured when dominant follicule is 17 mm in diameter and then serial measurements of hormones will be done and ovulation will be detected both hormonally and ultrasonographically. The range of serum progesterone will be reported referenced to ovulation.
Change of reproductive hormone levels referenced to ovulationEstradiol and LH levels will be measured serially when dominant follicule reaches 17 mm in diameter and after that 1-2 days interval until to ovulation.Serum estradiol and luteinising hormone (LH) levels will be measured when dominant folicule is 17 mm in diameter and then serial measurements of hormones will be done and ovulation will be detected both hormonally and ultrasonographically. The ranges for serum hormones will be reported.

Countries

Turkey (Türkiye)

Contacts

Primary ContactTurgut Aydın
turgut.aydin@acibadem.com+905323722713
Backup Contactnadiye köroğlu
nadiye_dugan@hotmail.com+905058065348

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026